COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The global live cell imaging market size is projected to reach USD 2.8 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 8.8% during the forecast period. The market for live cell imaging is driven primarily by the factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, growth in research funding, and rising government funding in regenerative medicine research. However, high cost of high-content screening systems will hinder the overall adoption of live cell imaging systems and thereby restrain market growth in the coming years.

“By instrument type, the microscopes segment holds the largest market share during the forecast period.”
Based on type, the live cell imaging instruments market is segmented into microscopes, standalone systems, cell analyzers, and accessories. The microscopes segment accounted for the largest share of the live cell imaging market in 2019. The large share of this segment can be attributed to the increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures to launch new instruments in the market.

“By application, the stem cells segment is expected to register the highest CAGR during the forecast period.”
Based on application, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. The stem cells segment is projected to register the highest CAGR during the forecast period. Factors such as the increasing stem cell research activities and investments.

“Asia Pacific (APAC) is projected to witness the highest growth during the forecast period.”
The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the government initiatives for research on stem cell therapy, increasing aging population, the rising prominence of regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.


The breakdown of primary participants was as mentioned below:

  • By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25%
  • By Designation: C-level Executives–35%, Directors–40%, and Others–25%
  • By Region: North America–35%, Europe–25%, Asia Pacific–20%, Latin America–10%, Middle East & Africa–10%


The leading players in this market include Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).

Research Coverage:
The report analyzes the various live cell imaging products and their adoption pattern. It aims at estimating the market size and future growth potential of the live cell imaging market for different segments such as product & service, application, technology, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.


Reasons To Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their position in the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the live cell imaging market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the live cell imaging market
  • Market Development: Comprehensive information on the lucrative emerging regions by product, application, technology, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the live cell imaging market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the live cell imaging market